Docusign (NASDAQ:DOCU) Price Target Cut to $99.00 by Analysts at Citigroup

Docusign (NASDAQ:DOCU) had its price objective lowered by equities research analysts at Citigroup from $120.00 to $99.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target would suggest a potential upside of 99.44% from the company’s current price.

DOCU has been the topic of a number of other reports. Bank of America decreased their price objective on Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a report on Friday, December 5th. HSBC set a $53.00 price target on Docusign in a research report on Friday, February 13th. JPMorgan Chase & Co. lowered their price target on Docusign from $78.00 to $65.00 and set a “neutral” rating on the stock in a research report on Wednesday. Morgan Stanley dropped their price objective on Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, Zacks Research cut shares of Docusign from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. Five analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, Docusign presently has an average rating of “Hold” and a consensus price target of $66.67.

Docusign Trading Up 4.4%

Shares of DOCU traded up $2.10 during mid-day trading on Wednesday, hitting $49.64. 9,285,837 shares of the company traded hands, compared to its average volume of 4,887,049. The stock has a market capitalization of $9.94 billion, a price-to-earnings ratio of 34.71, a PEG ratio of 2.04 and a beta of 1.03. The business has a 50-day moving average of $51.11 and a 200 day moving average of $64.46. Docusign has a one year low of $40.16 and a one year high of $94.67.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 15.02% and a net margin of 9.57%.The firm had revenue of $836.86 million during the quarter, compared to analyst estimates of $828.23 million. During the same period last year, the company earned $0.86 earnings per share. The company’s revenue was up 7.8% on a year-over-year basis. As a group, analysts anticipate that Docusign will post 1.17 earnings per share for the current year.

Insider Buying and Selling at Docusign

In other news, CRO Paula Hansen sold 6,000 shares of the stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $67.05, for a total transaction of $402,300.00. Following the sale, the executive directly owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This represents a 8.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 26,250 shares of the firm’s stock in a transaction on Friday, January 9th. The stock was sold at an average price of $69.60, for a total value of $1,827,000.00. Following the completion of the transaction, the chief executive officer owned 142,261 shares in the company, valued at $9,901,365.60. The trade was a 15.58% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 51,477 shares of company stock worth $3,521,607 over the last quarter. Company insiders own 1.66% of the company’s stock.

Institutional Trading of Docusign

A number of hedge funds and other institutional investors have recently modified their holdings of DOCU. Rockefeller Capital Management L.P. grew its position in shares of Docusign by 11.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 238,114 shares of the company’s stock valued at $16,287,000 after buying an additional 24,842 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of Docusign by 2.5% during the fourth quarter. Corient Private Wealth LLC now owns 29,608 shares of the company’s stock worth $2,026,000 after acquiring an additional 732 shares during the last quarter. Kera Capital Partners Inc. lifted its stake in shares of Docusign by 347.8% in the fourth quarter. Kera Capital Partners Inc. now owns 16,556 shares of the company’s stock worth $1,132,000 after acquiring an additional 12,859 shares during the period. Alberta Investment Management Corp boosted its holdings in Docusign by 490.2% in the fourth quarter. Alberta Investment Management Corp now owns 72,000 shares of the company’s stock valued at $4,925,000 after acquiring an additional 59,800 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its position in Docusign by 32.9% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 65,594 shares of the company’s stock valued at $4,487,000 after purchasing an additional 16,250 shares during the period. Institutional investors own 77.64% of the company’s stock.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results beat expectations — EPS $1.01 vs. $0.95 estimate and revenue ~$836.9M (up ~7.8% YoY); the beat and upbeat near‑term outlook helped lift shares. Article Title
• Positive Sentiment: Board authorized a $2.0 billion increase to the share‑repurchase program — a material capital‑return signal that can support the stock. Article Title
• Positive Sentiment: IAM / AI traction highlighted on the call — management cited IAM customers generating >$350M ARR and AI integrations as drivers for upsell and retention, supporting longer‑term revenue expansion. Article Title
• Positive Sentiment: Some shops remain bullish — BTIG reaffirmed a buy and Citizens/JMP kept an outperform stance with higher targets, showing pockets of analyst conviction. Article Title
• Neutral Sentiment: Full earnings materials and transcripts available — management provided slides and call commentary that investors can use to assess cadence of billings, churn and IAM expansion. Slide Deck / Press Release
• Neutral Sentiment: Analyst coverage still mixed — coverage includes deep‑dive pieces and valuation checks that highlight both improving margins and areas needing proof (sustained billings/growth). Article Title
• Negative Sentiment: Broad analyst price‑target cuts after results — multiple firms trimmed targets (examples: JPMorgan $78→$65, Morgan Stanley $90→$69, Piper Sandler $75→$52, UBS $75→$54, RBC $70→$55, Wells Fargo $75→$60, Baird $75→$55), reflecting caution on near‑term growth and execution. Article Title
• Negative Sentiment: Analysts remain on the sidelines on execution/growth — several notes call for clearer evidence of sustained 10%+ revenue growth before upgrading, keeping sentiment cautious despite the beat. Article Title

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.